The trademark application ITEGVO was filed by Eli Lilly and Company, a U.S. corporation (the "Applicant"). The application was published for oppositions on May 25, 2021, and it was registered by office on September 1, 2021 without any oppositions.
The application was filed in English (German was selected as the second language).